Nadim Mahmud, MD, MS, MPH, MSCE
Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
7 South Pavilion
Philadelphia, PA 19104
3400 Civic Center Boulevard
7 South Pavilion
Philadelphia, PA 19104
Office: 215-349-8222
Publications
Education
MS (Master of Science)
Yale University, 2008.
BS (Bachelor of Science)
Yale University, 2008.
MPH (Master of Public Health)
Columbia Mailman School of Public Health (Biostatistics and Clinical Trial Design), 2011.
MD (Doctor of Medicine)
Stanford University School of Medicine, 2013.
MSCE (Master of Science in Clinical Epidemiology)
University of Pennsylvania Perelman School of Medicine, 2019.
MS (Master of Science)
Yale University, 2008.
BS (Bachelor of Science)
Yale University, 2008.
MPH (Master of Public Health)
Columbia Mailman School of Public Health (Biostatistics and Clinical Trial Design), 2011.
MD (Doctor of Medicine)
Stanford University School of Medicine, 2013.
MSCE (Master of Science in Clinical Epidemiology)
University of Pennsylvania Perelman School of Medicine, 2019.
Links
Search PubMed for articles
VOCAL-Penn Cirrhosis Surgical Risk Score
IM Research Hub - developed, designed, and curated by Nadim Mahmud. Research resources for the Internal Medicine residency program at Penn.
Permanent linkSearch PubMed for articles
VOCAL-Penn Cirrhosis Surgical Risk Score
IM Research Hub - developed, designed, and curated by Nadim Mahmud. Research resources for the Internal Medicine residency program at Penn.
Selected Publications
Ochoa-Allemant P, Kiran A, Mezzacappa C, Kaplan DE, Mahmud N.: Steatotic Liver Disease has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the US Veterans Health System. Am J Gastroenterol 121(7), Jul 2026.Reza N, Mahmud N, Austin MA, Boakye E, Duqueney E, Patel P, de Feria A, Hornsby N, Marzolf A, Owens AT: Association between Baseline Hypertension and Longitudinal Functional Status in Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten. J Card Fail 32(7): 1277-1280, Jul 2026.
Hatipoglu D, Mahmud N: Integrated care is necessary, but not sufficient, for equity in hepatocellular carcinoma outcomes. Liver Transpl 32(7), Jul 2026.
Hatipoglu D, Kiran A, Mahmud N: Guidelines in Practice: Preoperative Risk Assessment and Management in Patients With Cirrhosis. Am J Gastroenterol Page: 10.14309/ajg.0000000000004043, May 2026.
Sarin SK, Choudhury A, Kumar A, Mahmud N, Lee GH, Ning Q, Tan SS, Thanapirom K, Arora V, Nakayama N, Li J, Karvellas CJ: Acute-on-chronic liver failure: pathophysiological mechanisms and clinical management. Nat Rev Gastroenterol Hepatol 23(5): 411-431, May 2026.
Agins J, Blandon C, Kaplan DE, John B, Mahmud N, Goldberg DS: Predicting severe liver dysfunction following locoregional therapy for early- and intermediate-stage hepatocellular carcinoma. Liver Transpl May 13 2026 Notes: doi: 10.1097/LVT.0000000000000901. Online ahead of print.
McCullough AA, Mahmud N, Reddy KR, Bittermann T: Delisting for clinical improvement as a proxy for recompensated cirrhosis on the U.S. liver transplant waitlist: A retrospective cohort study. Liver Transpl Apr 2026 Notes: Online ahead of print.
Ghodrati F, Mahmud N, Rattan P: HCV NAT+ consent improves liver transplant and waitlist mortality in patients listed for HCC MELD exceptions. Liver Transpl 32(4): 582-591, April 1 2026.
Mahmud N, Schechter MS, Zhang S, Mezzacappa C, Ochoa-Allemant P, Kaplan DE, Serper M: Intravenous albumin after outpatient paracentesis reduces the risk of AKI hospitalization: A national cohort study. Hepatology Mar 2026 Notes: doi: 10.1097/HEP.0000000000001739. Online ahead of print.
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, DE Feria A, Marzolf A, Owens AT: Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy. J Card Fail Intersect 2(2), Mar 2026.